查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1856796

伴侶動物基因組學和診斷市場預測至2032年：按疾病類型、動物類型、應用、最終用戶和地區分類的全球分析

Companion Animal Genomics & Diagnostics Market Forecasts to 2032 - Global Analysis By Disease Type, Animal Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球伴侶動物基因體學和診斷市場預計到 2025 年將達到 34 億美元，到 2032 年將達到 62 億美元，預測期內複合年成長率為 8.8%。

伴侶動物基因組學與診斷是獸醫學的一個分支，專注於寵物的基因分析。此領域對犬、貓和其他伴侶動物進行DNA定序和解讀，旨在識別品種特異性特徵、遺傳疾病易感性和獨特的遺傳特徵。診斷應用利用這些遺傳資訊進行遺傳疾病篩檢、確診以及了解疾病的潛在分子機制。這為理解個體動物的遺傳健康狀況提供了科學基礎。

據美國獸醫協會稱，基因序列測定和分子診斷技術的進步使得伴侶動物醫療保健領域能夠更早發現疾病並採取個人化的治療方法。

基因檢測技術的進步

基因檢測技術的進步正在革新伴侶動物基因組學和診斷市場，使遺傳疾病、疾病易感性和品種鑑定能夠精準識別。 DNA定序、生物標記分析和生物資訊平台的創新，正助力獸醫和寵物飼主實施個人化醫療保健策略。這些進步提高了診斷準確性，支持預防性護理，並促進疾病的早期介入。高通量定序、行動報告和雲端基礎分析的整合，正在擴大檢測的可及性和易用性，從而增強全球都市區獸醫診所的市場接受度。

高昂的診斷和定序成本

高昂的診斷和定序成本仍然是伴侶動物基因組學和診斷市場的主要限制因素，限制了注重成本的飼主採用這項技術。尤其是在新興經濟體，昂貴的檢測程序、實驗室費用和專有平台費用降低了技術的普及性。即使技術已經成熟，這些經濟障礙也會阻礙技術的廣泛應用。此外，針對特定症狀或後續觀察的重複檢測也會增加累積成本。市場參與者必須在技術先進性和價格可負擔之間取得平衡，以確保技術的持續成長，並促進不同飼主群體的廣泛應用。

與獸醫遠端醫療平台建立合作關係

與獸醫遠端醫療平台建立合作關係，為伴侶動物基因組學和診斷市場帶來了巨大的成長機會。將基因檢測與虛擬獸醫諮詢相結合，能夠實現遠距離診斷、個人化治療方案製定以及寵物疾病的早期發現。此類合作關係有助於將服務覆蓋到服務不足的偏遠地區，提升寵物飼主的便利性，並透過數位化平台加強互動。遠端醫療夥伴關係還可以支援基於訂閱的基因組監測，促進持續的健康管理，並為基因組學服務提供者帶來穩定的收入來源。

基因資料庫中的資料隱私風險

基因資料庫中的資料隱私風險對伴侶動物基因組學和診斷市場構成重大威脅。敏感的基因組資訊可能容易受到未授權存取、網路攻擊和濫用。資料外洩可能危及寵物飼主的隱私，削弱服務供應商的信任，並使您面臨監管審查。安全儲存、維護加密通訊協定以及遵守國家和國際資料保護法律至關重要。未能有效管理這些風險可能會影響市場採用率，阻礙夥伴關係，並損害在競爭激烈的基因組診斷領域的品牌聲譽。

新冠疫情的影響：

新冠疫情的爆發加速了居家檢測和遠端醫療服務的需求，從而對伴侶動物基因組學和診斷市場產生了影響。寵物飼主擴大尋求遠端解決方案進行預防保健和基因篩檢，以減少就診次數。實驗室運作也隨之調整，採用數位化報告、非接觸式樣本採集和宅配套件等方式。然而，供應鏈中斷和樣本處理延遲暫時影響了市場活動。整體而言，疫情凸顯了遠距離診斷服務和數位整合的重要性，鞏固了伴侶動物基因體學的長期成長前景。

預測期內，感染疾病將是最大的細分市場。

感染疾病領域在伴侶動物基因組學和診斷市場中佔據顯著佔有率，預計在預測期內仍將保持最大的市場佔有率。細菌、病毒和感染疾病感染的治療有助於早期發現、精準治療並改善動物福利。由於傳染病的高發生率和跨物種傳播的可能性，獸醫診所和診斷實驗室將感染疾病篩檢列為優先事項。基因譜分析的整合能夠強化預防策略、支持疫苗接種計畫並確保精準干預，使該領域在未來幾年成為整體市場收入的重要貢獻者。

預計在預測期內，犬類市場將以最高的複合年成長率成長。

預計在預測期內，犬類市場將實現最高成長率，這主要得益於養犬人數的增加、寵物擬人化趨勢的興起以及人們對特定犬種健康狀況日益成長的關注。犬飼主擴大投資於基因檢測，用於疾病預防、追溯犬種血統和個人化營養。犬類基因體學的進步，加上遠距遠端醫療的日益普及，使得早期診斷介入更加便捷有效率。消費者的高度關注以及重複檢測的潛力，使得犬類市場成為收入成長的關鍵驅動力，這反映出已開發市場和新興市場均呈現強勁的成長趨勢。

比最大的地區

預計亞太地區將在預測期內佔據最大的市場佔有率。這主要歸功於快速的都市化、寵物擁有率的上升以及人們對獸醫保健意識的增強。中國、日本和印度等國家對先進的伴侶動物診斷技術表現出越來越濃厚的興趣。遠端醫療基礎設施的擴展、可支配收入的增加以及數位素養的提高將進一步推動市場滲透。這些因素共同作用，使該地區成為全球市場收入的重要貢獻者，並促進了都市區和半都市區獸醫診斷行業的成長。

複合年成長率最高的地區：

在預測期內，北美預計將呈現最高的複合年成長率，這主要得益於其先進的獸醫基礎設施、較高的寵物擁有率以及基因組技術的廣泛應用。美國和加拿大受益於完善的遠端醫療平台、一體化的獸醫網路以及技術成熟度。消費者在預防性護理和個人化寵物健康解決方案方面的高支出進一步推動了市場成長。這些因素，加上有利的法律規範和創新基因組學公司，使北美成為伴侶動物基因組學和診斷領域成長最快的區域市場。

免費客製化服務：

訂閱本報告的用戶可享有以下免費客製化服務之一：

  • 公司簡介
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行市場估算、預測和複合年成長率分析（註：基於可行性檢查）
  • 競爭基準化分析
    • 基於產品系列、地域覆蓋和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究資訊來源
    • 初級研究資訊來源
    • 次級研究資訊來源
    • 先決條件

第3章 市場趨勢分析

  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球伴侶動物基因體學和診斷市場（按疾病類型分類）

  • 感染疾病
  • 慢性病
  • 癌症/腫瘤檢測
  • 遺傳性疾病
  • 內分泌疾病
  • 其他疾病類型

6. 全球伴侶動物基因體學和診斷市場（按動物類型分類）

  • 狗
  • 貓
  • 馬
  • 其他動物類型

7. 全球伴侶動物基因體學和診斷市場（按應用分類）

  • 臨床病理
  • 毒理學
  • 細菌學
  • 寄生蟲學
  • 妊娠測試
  • 其他用途

8. 全球伴侶動物基因體學和診斷市場（按最終用戶分類）

  • 獸醫醫院和診所
  • 診斷實驗室
  • 研究所
  • 就地檢驗
  • 居家照護

9. 全球伴侶動物基因體學和診斷市場（按地區分類）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章：重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與併購
  • 新產品上市
  • 業務拓展
  • 其他關鍵策略

第11章 企業概況

  • Mars Petcare
  • Embark Veterinary
  • Zoetis
  • IDEXX Laboratories
  • Basepaws
  • Neogen
  • Orivet Genetic Pet Care
  • Paw Print Genetics
  • VetGen
  • Animal Genetics Inc.
  • UC Davis Veterinary Genetics Laboratory
  • Genoscoper
  • EasyDNA
  • Heska Corporation
  • Genetic Veterinary Sciences
  • Virbac
  • Nestle Purina
  • Royal Canin
Product Code: SMRC31668

According to Stratistics MRC, the Global Companion Animal Genomics & Diagnostics Market is accounted for $3.4 billion in 2025 and is expected to reach $6.2 billion by 2032 growing at a CAGR of 8.8% during the forecast period. Companion Animal Genomics & Diagnostics is a field of veterinary science focused on the genetic analysis of pets. It involves sequencing and interpreting the DNA of dogs, cats, and other companion animals. This discipline identifies breed-specific composition, inherited disease predispositions, and unique genetic traits. Diagnostic applications use this genetic information to screen for hereditary conditions, confirm diagnoses, and understand the underlying molecular causes of diseases. It provides a scientific basis for understanding an individual animal's genetic health profile.

According to the American Veterinary Medical Association, advancements in genomic sequencing and molecular diagnostics are enabling earlier disease detection and personalized treatment approaches in companion animal healthcare.

Market Dynamics:

Driver:

Technological advancements in genetic testing

Technological advancements in genetic testing have revolutionized the Companion Animal Genomics & Diagnostics Market, enabling precise identification of hereditary conditions, disease predispositions, and breed verification. Innovations in DNA sequencing, biomarker analysis, and bioinformatics platforms allow veterinarians and pet owners to implement personalized healthcare strategies. These advancements enhance diagnostic accuracy, support preventive care, and facilitate early disease intervention. Integration of high-throughput sequencing, mobile reporting, and cloud-based analytics has expanded accessibility and usability, strengthening the market's adoption across urban and rural veterinary practices globally.

Restraint:

High diagnostic and sequencing costs

High diagnostic and sequencing costs remain a significant restraint in the Companion Animal Genomics & Diagnostics Market, limiting adoption among cost-sensitive pet owners. Expensive testing procedures, laboratory fees, and proprietary platform charges reduce accessibility, particularly in emerging economies. This financial barrier can impede widespread implementation despite technological readiness. Additionally, recurrent testing for certain conditions or follow-ups increases cumulative costs. Market players must balance technological sophistication with affordability to ensure sustained growth and broader adoption across diverse pet owner demographics.

Opportunity:

Partnerships with veterinary telehealth platforms

Partnerships with veterinary telehealth platforms present a substantial growth opportunity in the Companion Animal Genomics & Diagnostics Market. Integrating genetic testing with virtual veterinary consultations enables remote diagnostics, personalized treatment plans, and early disease detection for pets. Such collaborations expand reach to underserved or rural areas, increase convenience for pet owners, and enhance engagement through digital platforms. Telehealth partnerships can also support subscription-based genomic monitoring, promoting continuous health management and driving recurring revenue streams for genomics service providers.

Threat:

Data privacy risks in genetic databases

Data privacy risks in genetic databases pose a notable threat to the Companion Animal Genomics & Diagnostics Market. Sensitive genomic information can be vulnerable to unauthorized access, cyberattacks, or misuse. Breaches may compromise pet owner confidentiality, undermine trust in service providers, and attract regulatory scrutiny. Maintaining secure storage, encryption protocols, and compliance with local and international data protection laws is critical. Failure to manage these risks effectively can impact adoption rates, hinder partnerships, and damage brand reputation in the competitive genomic diagnostics sector.

Covid-19 Impact:

The Covid-19 pandemic influenced the Companion Animal Genomics & Diagnostics Market by accelerating demand for at-home testing and telehealth services. Pet owners increasingly sought remote solutions for preventive care and genetic screening to reduce clinic visits. Laboratory operations adapted with digital reporting, contactless sample collection, and home delivery kits. However, supply chain disruptions and delayed sample processing temporarily impacted market activity. Overall, the pandemic highlighted the importance of remote diagnostic services and digital integration, reinforcing long-term growth prospects in companion animal genomics.

The infectious diseases segment is expected to be the largest during the forecast period

The infectious diseases segment is expected to account for the largest market share during the forecast period, accounting for a substantial share of the Companion Animal Genomics & Diagnostics Market. Testing for bacterial, viral, and parasitic infections enables early detection, accurate treatment, and improved animal welfare. Veterinary clinics and diagnostic laboratories prioritize infectious disease screening due to high prevalence and potential cross-species transmission. Integration with genetic profiling enhances preventive strategies, supports vaccination planning, and ensures targeted interventions, solidifying this segment as the primary contributor to overall market revenue over the coming years.

The dogs segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the dogs segment is predicted to witness the highest growth rate, propelled by increasing dog ownership, pet humanization, and rising awareness of breed-specific health conditions. Dog owners increasingly invest in genetic testing for disease prevention, ancestry tracking, and personalized nutrition. Advances in canine genomics, coupled with growing telehealth adoption, facilitate convenient and early diagnostic interventions. High consumer engagement and repeat testing potential make the dogs segment a critical driver of revenue growth, reflecting strong adoption trends across both developed and emerging markets.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, attributed to rapid urbanization, rising pet adoption rates, and increasing veterinary healthcare awareness. Countries like China, Japan, and India exhibit growing interest in advanced companion animal diagnostics. Expanding telehealth infrastructure, rising disposable incomes, and increasing digital literacy further enhance market penetration. Collectively, these factors establish the region as a dominant contributor to global market revenue, supporting growth in both urban and semi-urban veterinary diagnostics segments.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR associated with advanced veterinary infrastructure, high pet ownership, and strong adoption of genomic technologies. The United States and Canada benefit from widespread telehealth platforms, veterinary network integration, and technological readiness. High consumer spending on preventive care and personalized pet health solutions further accelerates market growth. These conditions, combined with supportive regulatory frameworks and innovation-driven genomics companies, position North America as the fastest-growing regional market in companion animal genomics and diagnostics.

Key players in the market

Some of the key players in Companion Animal Genomics & Diagnostics Market include Mars Petcare, Embark Veterinary, Zoetis, IDEXX Laboratories, Basepaws, Neogen, Orivet Genetic Pet Care, Paw Print Genetics, VetGen, Animal Genetics Inc., UC Davis Veterinary Genetics Laboratory, Genoscoper, EasyDNA, Heska Corporation, Genetic Veterinary Sciences, Virbac, Nestle Purina, and Royal Canin.

Key Developments:

In August 2025, Embark Veterinary announced the new "Breed + Health Kit" with expanded screening for over 250 genetic health conditions and traits in dogs, providing breeders and owners with more comprehensive hereditary disease risk reports.

In July 2025, Zoetis launched the new Vetscan Imagyst(R) platform with integrated genomic analysis, designed to combine AI-powered digital cytology with genetic testing for streamlined in-clinic diagnostic workflows for companion animals.

In June 2025, IDEXX Laboratories announced the launch of its "Make in India" initiative for the IDEXX Genetic Intelligence Panel to support the expansion of affordable, localized premium diagnostic services for pets across the region.

Disease Types Covered:

  • Infectious Diseases
  • Chronic Diseases
  • Cancer & Tumor Detection
  • Genetic Disorders
  • Endocrine Disorders
  • Other Disease Types

Animal Types Covered:

  • Dogs
  • Cats
  • Horses
  • Other Animal Types

Applications Covered:

  • Clinical Pathology
  • Toxicology
  • Bacteriology
  • Parasitology
  • Pregnancy Testing
  • Other Applications

End Users Covered:

  • Veterinary Hospitals & Clinics
  • Diagnostic Laboratories
  • Research Institutions
  • Point-of-Care Testing
  • Home Care

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Companion Animal Genomics & Diagnostics Market, By Disease Type

  • 5.1 Introduction
  • 5.2 Infectious Diseases
  • 5.3 Chronic Diseases
  • 5.4 Cancer & Tumor Detection
  • 5.5 Genetic Disorders
  • 5.6 Endocrine Disorders
  • 5.7 Other Disease Types

6 Global Companion Animal Genomics & Diagnostics Market, By Animal Type

  • 6.1 Introduction
  • 6.2 Dogs
  • 6.3 Cats
  • 6.4 Horses
  • 6.5 Other Animal Types

7 Global Companion Animal Genomics & Diagnostics Market, By Application

  • 7.1 Introduction
  • 7.2 Clinical Pathology
  • 7.3 Toxicology
  • 7.4 Bacteriology
  • 7.5 Parasitology
  • 7.6 Pregnancy Testing
  • 7.7 Other Applications

8 Global Companion Animal Genomics & Diagnostics Market, By End User

  • 8.1 Introduction
  • 8.2 Veterinary Hospitals & Clinics
  • 8.3 Diagnostic Laboratories
  • 8.4 Research Institutions
  • 8.5 Point-of-Care Testing
  • 8.6 Home Care

9 Global Companion Animal Genomics & Diagnostics Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Mars Petcare
  • 11.2 Embark Veterinary
  • 11.3 Zoetis
  • 11.4 IDEXX Laboratories
  • 11.5 Basepaws
  • 11.6 Neogen
  • 11.7 Orivet Genetic Pet Care
  • 11.8 Paw Print Genetics
  • 11.9 VetGen
  • 11.10 Animal Genetics Inc.
  • 11.11 UC Davis Veterinary Genetics Laboratory
  • 11.12 Genoscoper
  • 11.13 EasyDNA
  • 11.14 Heska Corporation
  • 11.15 Genetic Veterinary Sciences
  • 11.16 Virbac
  • 11.17 Nestle Purina
  • 11.18 Royal Canin

List of Tables

  • Table 1 Global Companion Animal Genomics & Diagnostics Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Companion Animal Genomics & Diagnostics Market Outlook, By Disease Type (2024-2032) ($MN)
  • Table 3 Global Companion Animal Genomics & Diagnostics Market Outlook, By Infectious Diseases (2024-2032) ($MN)
  • Table 4 Global Companion Animal Genomics & Diagnostics Market Outlook, By Chronic Diseases (2024-2032) ($MN)
  • Table 5 Global Companion Animal Genomics & Diagnostics Market Outlook, By Cancer & Tumor Detection (2024-2032) ($MN)
  • Table 6 Global Companion Animal Genomics & Diagnostics Market Outlook, By Genetic Disorders (2024-2032) ($MN)
  • Table 7 Global Companion Animal Genomics & Diagnostics Market Outlook, By Endocrine Disorders (2024-2032) ($MN)
  • Table 8 Global Companion Animal Genomics & Diagnostics Market Outlook, By Other Disease Types (2024-2032) ($MN)
  • Table 9 Global Companion Animal Genomics & Diagnostics Market Outlook, By Animal Type (2024-2032) ($MN)
  • Table 10 Global Companion Animal Genomics & Diagnostics Market Outlook, By Dogs (2024-2032) ($MN)
  • Table 11 Global Companion Animal Genomics & Diagnostics Market Outlook, By Cats (2024-2032) ($MN)
  • Table 12 Global Companion Animal Genomics & Diagnostics Market Outlook, By Horses (2024-2032) ($MN)
  • Table 13 Global Companion Animal Genomics & Diagnostics Market Outlook, By Other Animal Types (2024-2032) ($MN)
  • Table 14 Global Companion Animal Genomics & Diagnostics Market Outlook, By Application (2024-2032) ($MN)
  • Table 15 Global Companion Animal Genomics & Diagnostics Market Outlook, By Clinical Pathology (2024-2032) ($MN)
  • Table 16 Global Companion Animal Genomics & Diagnostics Market Outlook, By Toxicology (2024-2032) ($MN)
  • Table 17 Global Companion Animal Genomics & Diagnostics Market Outlook, By Bacteriology (2024-2032) ($MN)
  • Table 18 Global Companion Animal Genomics & Diagnostics Market Outlook, By Parasitology (2024-2032) ($MN)
  • Table 19 Global Companion Animal Genomics & Diagnostics Market Outlook, By Pregnancy Testing (2024-2032) ($MN)
  • Table 20 Global Companion Animal Genomics & Diagnostics Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 21 Global Companion Animal Genomics & Diagnostics Market Outlook, By End User (2024-2032) ($MN)
  • Table 22 Global Companion Animal Genomics & Diagnostics Market Outlook, By Veterinary Hospitals & Clinics (2024-2032) ($MN)
  • Table 23 Global Companion Animal Genomics & Diagnostics Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN)
  • Table 24 Global Companion Animal Genomics & Diagnostics Market Outlook, By Research Institutions (2024-2032) ($MN)
  • Table 25 Global Companion Animal Genomics & Diagnostics Market Outlook, By Point-of-Care Testing (2024-2032) ($MN)
  • Table 26 Global Companion Animal Genomics & Diagnostics Market Outlook, By Home Care (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.